BSE · GUJTERC

Gujarat Terce Laboratories Ltd

Sector: Healthcare · ISIN: INE499G01013

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,837

of 5,084 stocks

▼ 291W

Peak #3,776 · 27 Sep 2026

Operating in Healthcare, Gujarat Terce Laboratories Ltd generates a high return on equity, is seeing revenue slip, and trades at a moderate earnings multiple. Ownership as of Jun 2026.

Market Cap

28.24 Cr

P/E Ratio

12.41

P/B Ratio

2.90

ROE

22.63%

ROCE

26.94%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	9.00 Cr	11.40 Cr	12.29 Cr	12.93 Cr
Net Profit	-17.81 L	10.10 L	76.11 L	1.40 Cr
EPS	0.23	0.13	0.95	1.89
Operating Profit	-11.64 L	68.39 L	1.17 Cr	1.85 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

40.03%

Public

59.97%

PUBLIC BREAKDOWN

Individuals

56.19%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs